Enumeration and changes in circulating tumor cells and their prognostic value in patients undergoing cytoreductive radical prostatectomy for oligometastatic prostate …

PC Mandel, H Huland, A Tiebel, A Haese… - European urology …, 2021 - Elsevier
Background The prognostic value of circulating tumor cells (CTCs) in patients with hormone-
naïve oligometastatic prostate cancer (HNoMPC) undergoing cytoreductive radical …

Enumeration and Changes in Circulating Tumor Cells and Their Prognostic Value in Patients Undergoing Cytoreductive Radical Prostatectomy for Oligometastatic …

PC Mandel, H Huland, A Tiebel… - European …, 2021 - pubmed.ncbi.nlm.nih.gov
Background The prognostic value of circulating tumor cells (CTCs) in patients with hormone-
naïve oligometastatic prostate cancer (HNoMPC) undergoing cytoreductive radical …

Enumeration and Changes in Circulating Tumor Cells and Their Prognostic Value in Patients Undergoing Cytoreductive Radical Prostatectomy for Oligometastatic …

PC Mandel, H Huland, A Tiebel… - European …, 2021 - eu-focus.europeanurology.com
Background The prognostic value of circulating tumor cells (CTCs) in patients with hormone-
naïve oligometastatic prostate cancer (HNoMPC) undergoing cytoreductive radical …

Enumeration and Changes in Circulating Tumor Cells and Their Prognostic Value in Patients Undergoing Cytoreductive Radical Prostatectomy for Oligometastatic …

PC Mandel, H Huland, A Tiebel, A Haese… - European Urology …, 2019 - europepmc.org
Background The prognostic value of circulating tumor cells (CTCs) in patients with hormone-
naïve oligometastatic prostate cancer (HNoMPC) undergoing cytoreductive radical …